> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Antimicrobial Drugs Advisory Committee Meeting on Bacitracin
- URL: https://www.fdaweb.com/antimicrobial-drugs-advisory-committee-meeting-on-bacitracin/
- Published: 2019-03-22T12:00:00.000Z
- Updated: 2026-09-15T01:15:05.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5143681

*Federal Register* notice: FDA has announced a 4/26 Antimicrobial Drugs Advisory Committee meeting. Panel members are scheduled to discuss the safety and effectiveness of bacitracin for intramuscular injection for treating infants with pneumonia and empyema caused by *staphylococci* shown to be susceptible to the drug, which is the only approved indication for bacitracin for intramuscular injection. The committee will also consider whether there are other uses for bacitracin for intramuscular injection that could be studied. To view the notice, click [here](https://s3.amazonaws.com/public-inspection.federalregister.gov/2019-05652.pdf?ref=fdaweb.com).